P43 FIB-4 is superior to APRI and identifies HCV patients with less significant fibrosis who could be managed in primary care
Saved in:
Main Authors: | J. O'Beirne (Author), J.D. Mitchell (Author), A. Sloss (Author), B. Kay (Author), S. Higgins (Author), C. Orme (Author), A. Azzam (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
P44 Maximising access to hepatitis C (HCV) treatment: the Sunshine Coast experience
by: J. O'Beirne, et al.
Published: (2017) -
Determination of liver damage indices APRI and FIB-4 score in adolescents with juvenile idiopathic arthritis
by: L.A. Strashok, et al.
Published: (2020) -
FIB-4 and APRI scores for progressive liver fibrosis diagnosis in children with biliary atresia
by: Hongyu Lyu, et al.
Published: (2024) -
CORRELATION OF FIB-4 AND APRI SCORE WITH FIBRO SCAN SCORE TO PREDICT FIBROSIS IN OBESE TYPE-2 DIABETIC PATIENTS.
by: Amit Kumar Das, et al.
Published: (2023) -
Serum YKL-40 (Chitinase-3-Like Protein 1) Compared to APRI and FIB-4 in Predicting Liver Fibrosis in Children with Chronic Hepatitis C
by: Mostafa Mohamed Sira, et al.
Published: (2016)